Arvinas (ARVN) EBIT Margin (QoQ) (2017 - 2026)
Arvinas (ARVN) EBIT Margin (QoQ) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Arvinas |
492.16 Mn |
-122.74 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
37,629.00 |
| Dec 31, 2025 |
-68,073.00 |
| Sep 30, 2025 |
21,466.00 |
| Jun 30, 2025 |
-35,701.00 |
| Mar 31, 2025 |
13,613.00 |
| Dec 31, 2024 |
-3,942.00 |
| Sep 30, 2024 |
451.00 |
| Jun 30, 2024 |
26,585.00 |
| Mar 31, 2024 |
-71,278.00 |
| Dec 31, 2023 |
59,711.00 |
| Sep 30, 2023 |
-7,670.00 |
| Jun 30, 2023 |
13,297.00 |
| Mar 31, 2023 |
-6,985.00 |
| Dec 31, 2022 |
-633.00 |
| Sep 30, 2022 |
100.00 |
| Jun 30, 2022 |
2,306.00 |
| Mar 31, 2022 |
-7,466.00 |
| Dec 31, 2021 |
36,553.00 |
| Sep 30, 2021 |
43,503.00 |
| Jun 30, 2021 |
-18,545.00 |
